← Back to Search

Communication Tool Training for Kidney Failure

N/A

Waitlist Available

Led By Jeniann Yi, MD

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Currently on dialysis

Do not speak English

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from enrollment for up to 2 years

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether the "Best Case/Worse Case" communication tool can help patients with end-stage renal disease receive appropriate palliative care and improve communication between patients and their caregivers.

Who is the study for?

This trial is for older adults with severe kidney disease (eGFR ≤ 24) who are not on dialysis but may have had it before or have the access in place. They must be over 80, have other serious illnesses, or their doctor wouldn't be surprised if they passed away within a year. Participants should speak English and be able to make decisions.

What is being tested?

The study tests a 'Best Case/Worst Case' communication tool training for doctors at nephrology clinics. It aims to see if this improves end-of-life care quality and decision-making for patients with end-stage renal disease by comparing trained doctors to those waiting for training.

What are the potential side effects?

Since this trial involves communication training rather than medical treatment, there are no direct physical side effects expected from participating in the study.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently receiving dialysis.

Select...

I do not speak English.

Select...

I am unable to make my own medical decisions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from enrollment for up to 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from enrollment for up to 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and from enrollment for up to 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Receipt of palliative care consult within 12 months of study enrollment, as determined by chart review or report by patient or caregiver

Secondary study objectives

Caregiver-reported general quality of communication (QOC) received from study nephrologist

Caregiver-reported health related quality of life

Caregiver-reported quality of dying and death

+13 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Best Case/Worst Case communication toolExperimental Treatment1 Intervention

The participant's enrolled nephrologist will have completed training on the Best Case/Worst Case communication tool and will be encouraged to use it with the participant.

Group II: Usual CareActive Control1 Intervention

Usual care conversations are typically focused on mode and timing of dialysis, management of electrolytes and scheduling of laboratory testing. Conservative management or a treatment option of "no dialysis" is rarely mentioned.

0 / 3Eligibility criteria met